These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 7849311)

  • 21. Deletion of cyclin-dependent kinase 4 inhibitor genes P15 and P16 in non-Hodgkin's lymphoma.
    Koduru PR; Zariwala M; Soni M; Gong JZ; Xiong Y; Broome JD
    Blood; 1995 Oct; 86(8):2900-5. PubMed ID: 7579381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The 9p21 region in bladder cancer cell lines: large homozygous deletion inactivate the CDKN2, CDKN2B and MTAP genes.
    Stadler WM; Olopade OI
    Urol Res; 1996; 24(4):239-44. PubMed ID: 8873383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma.
    Elenitoba-Johnson KS; Gascoyne RD; Lim MS; Chhanabai M; Jaffe ES; Raffeld M
    Blood; 1998 Jun; 91(12):4677-85. PubMed ID: 9616165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence and clinical significance of CDKN2/MTS1/P16ink4A and MTS2/P15ink4B gene deletions in childhood acute lymphoblastic leukemia.
    Zhou M; Gu L; Yeager AM; Findley HW
    Pediatr Hematol Oncol; 1997; 14(2):141-50. PubMed ID: 9089742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of CDKN2 (p16INK4A/MTS1) and p15INK4B/MTS2 in human leukemias and lymphomas.
    Otsuki T; Clark HM; Wellmann A; Jaffe ES; Raffeld M
    Cancer Res; 1995 Apr; 55(7):1436-40. PubMed ID: 7882348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between deletion of the CDKN2 gene and tyrosine kinase inhibitor resistance in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Xu N; Li YL; Li X; Zhou X; Cao R; Li H; Li L; Lu ZY; Huang JX; Fan ZP; Huang F; Zhou HS; Zhang S; Liu Z; Zhu HQ; Liu QF; Liu XL
    J Hematol Oncol; 2016 Apr; 9():40. PubMed ID: 27090891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential role for concurrent abnormalities of the cyclin D1, p16CDKN2 and p15CDKN2B genes in certain B cell non-Hodgkin's lymphomas. Functional studies in a cell line (Granta 519).
    Jadayel DM; Lukas J; Nacheva E; Bartkova J; Stranks G; De Schouwer PJ; Lens D; Bartek J; Dyer MJ; Kruger AR; Catovsky D
    Leukemia; 1997 Jan; 11(1):64-72. PubMed ID: 9001420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deletion mapping of chromosome region 9p21-p22 surrounding the CDKN2 locus in melanoma.
    Ohta M; Berd D; Shimizu M; Nagai H; Cotticelli M-G ; Mastrangelo M; Shields JA; Shields CL; Croce CM; Huebner K
    Int J Cancer; 1996 Mar; 65(6):762-7. PubMed ID: 8631588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chromosome 9p allelic loss and p16/CDKN2 in breast cancer and evidence of p16 inactivation in immortal breast epithelial cells.
    Brenner AJ; Aldaz CM
    Cancer Res; 1995 Jul; 55(13):2892-5. PubMed ID: 7796417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations of CDKN2 gene structure in childhood acute lymphoblastic leukemia: mutations of CDKN2 are observed preferentially in T lineage.
    Nakao M; Yokota S; Kaneko H; Seriu T; Koizumi S; Takaue Y; Fujimoto T; Misawa S
    Leukemia; 1996 Feb; 10(2):249-54. PubMed ID: 8637233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deletion of chromosome arm 3p in hematologic malignancies.
    Johansson B; Billström R; Kristoffersson U; Akerman M; Garwicz S; Ahlgren T; Malm C; Mitelman F
    Leukemia; 1997 Aug; 11(8):1207-13. PubMed ID: 9264371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities.
    Hunger SP; Tkachuk DC; Amylon MD; Link MP; Carroll AJ; Welborn JL; Willman CL; Cleary ML
    Blood; 1993 Jun; 81(12):3197-203. PubMed ID: 8389614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of chromosome arm 9p DNA and analysis of the p16 and p15 cyclin-dependent kinase inhibitor genes in human parathyroid adenomas.
    Tahara H; Smith AP; Gaz RD; Arnold A
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3663-7. PubMed ID: 8855819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of clonal rearrangements of the Ig heavy chain locus in acute leukemia.
    Height SE; Swansbury GJ; Matutes E; Treleaven JG; Catovsky D; Dyer MJ
    Blood; 1996 Jun; 87(12):5242-50. PubMed ID: 8652839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular analysis of cyclin-dependent kinase inhibitors in human leukemias.
    Hayette S; Thomas X; Bertrand Y; Tigaud I; Callanan M; Thiebaut A; Charrin C; Archimbaud E; Magaud JP; Rimokh R
    Leukemia; 1997 Oct; 11(10):1696-9. PubMed ID: 9324291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of inactivation of CDKN2 and MTS2 in non-small cell lung cancer and association with advanced stage.
    Nakagawa K; Conrad NK; Williams JP; Johnson BE; Kelley MJ
    Oncogene; 1995 Nov; 11(9):1843-51. PubMed ID: 7478613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p16ink4a gene and hematological malignancies.
    Quesnel B; Preudhomme C; Fenaux P
    Leuk Lymphoma; 1996 Jun; 22(1-2):11-24. PubMed ID: 8724524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Partial deletions of the CDKN2 and MTS2 putative tumor suppressor genes in a myxoid chondrosarcoma.
    Jagasia AA; Block JA; Diaz MO; Nobori T; Gitelis S; Inerot SE; Iyer AP
    Cancer Lett; 1996 Jul; 105(1):77-90. PubMed ID: 8689636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TEL-AML1 translocations with TEL and CDKN2 inactivation in acute lymphoblastic leukemia cell lines.
    Kim DH; Moldwin RL; Vignon C; Bohlander SK; Suto Y; Giordano L; Gupta R; Fears S; Nucifora G; Rowley JD
    Blood; 1996 Aug; 88(3):785-94. PubMed ID: 8704231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. P16INK4A gene homozygous deletions in human acute leukaemias with alterations of chromosome 9.
    Faienza MF; della Ragione F; Basso G; Coppola B; Miraglia del Giudice E; Schettini F; Iolascon A
    Br J Haematol; 1996 Jun; 93(3):632-6. PubMed ID: 8652384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.